Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Cortical response to levodopa in Parkinson's disease patients with dyskinesias.

Turco F, Canessa A, Olivieri C, Pozzi NG, Palmisano C, Arnulfo G, Marotta G, Volkmann J, Pezzoli G, Isaias IU.

Eur J Neurosci. 2018 Aug 17. doi: 10.1111/ejn.14114. [Epub ahead of print]

PMID:
30117212
2.

Pathological Gambling in Parkinson's disease: Autonomic measures supporting impaired decision-making.

Angioletti L, Siri C, Meucci N, Pezzoli G, Balconi M.

Eur J Neurosci. 2018 Jun 11. doi: 10.1111/ejn.13993. [Epub ahead of print]

PMID:
29888425
3.

Phase matters: A role for the subthalamic network during gait.

Arnulfo G, Pozzi NG, Palmisano C, Leporini A, Canessa A, Brumberg J, Pezzoli G, Matthies C, Volkmann J, Isaias IU.

PLoS One. 2018 Jun 6;13(6):e0198691. doi: 10.1371/journal.pone.0198691. eCollection 2018.

4.

Nutritional characterisation of Zambian Moringa oleifera: acceptability and safety of short-term daily supplementation in a group of malnourished girls.

Barichella M, Pezzoli G, Faierman SA, Raspini B, Rimoldi M, Cassani E, Bertoli S, Battezzati A, Leone A, Iorio L, Ferri V, Pinelli G, Pusani C, Bolliri C, Cilia R, Caronni S, De Marco P, Cereda E.

Int J Food Sci Nutr. 2018 May 24:1-9. doi: 10.1080/09637486.2018.1475550. [Epub ahead of print]

PMID:
29792366
5.

Multiple system atrophy and CAG repeat length: A genetic screening of polyglutamine disease genes in Italian patients.

Mongelli A, Sarro L, Rizzo E, Nanetti L, Meucci N, Pezzoli G, Goldwurm S, Taroni F, Mariotti C, Gellera C.

Neurosci Lett. 2018 Jun 21;678:37-42. doi: 10.1016/j.neulet.2018.04.044. Epub 2018 Apr 30.

PMID:
29715545
6.

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.

Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, Pezzoli G, Langley J, Hu XP, Zucca FA, Isaias IU, Zecca L.

NPJ Parkinsons Dis. 2018 Apr 10;4:11. doi: 10.1038/s41531-018-0047-3. eCollection 2018. Review.

7.

Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson's Disease.

Balconi M, Siri C, Meucci N, Pezzoli G, Angioletti L.

J Parkinsons Dis. 2018;8(2):341-352. doi: 10.3233/JPD-171290.

PMID:
29614700
8.

Gambling behavior in Parkinson's Disease: Impulsivity, reward mechanism and cortical brain oscillations.

Balconi M, Angioletti L, Siri C, Meucci N, Pezzoli G.

Psychiatry Res. 2018 Mar 20. pii: S0165-1781(17)31835-8. doi: 10.1016/j.psychres.2018.03.041. [Epub ahead of print]

PMID:
29580652
9.

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1.

Perez Carrion M, Pischedda F, Biosa A, Russo I, Straniero L, Civiero L, Guida M, Gloeckner CJ, Ticozzi N, Tiloca C, Mariani C, Pezzoli G, Duga S, Pichler I, Pan L, Landers JE, Greggio E, Hess MW, Goldwurm S, Piccoli G.

Front Mol Neurosci. 2018 Feb 28;11:64. doi: 10.3389/fnmol.2018.00064. eCollection 2018.

10.

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.

Calogero AM, Viganò M, Budelli S, Galimberti D, Fenoglio C, Cartelli D, Lazzari L, Lehenkari P, Canesi M, Giordano R, Cappelletti G, Pezzoli G.

J Cell Mol Med. 2018 May;22(5):2670-2679. doi: 10.1111/jcmm.13545. Epub 2018 Mar 4.

11.

Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.

Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G.

Parkinsonism Relat Disord. 2018 Apr;49:60-66. doi: 10.1016/j.parkreldis.2018.01.014. Epub 2018 Jan 11.

PMID:
29352722
12.

Factors influencing psychological well-being in patients with Parkinson's disease.

Nicoletti A, Mostile G, Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, De Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Zappia M.

PLoS One. 2017 Dec 15;12(12):e0189682. doi: 10.1371/journal.pone.0189682. eCollection 2017.

13.

Divergent Thinking in Parkinsonism: A Case-Control Study.

Canesi M, Rusconi ML, Cereda E, Ranghetti A, Cereda V, Moroni F, Pezzoli G.

Front Neurol. 2017 Oct 25;8:534. doi: 10.3389/fneur.2017.00534. eCollection 2017.

14.

Evaluating psychiatric symptoms in Parkinson's Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R).

Carrozzino D, Morberg BM, Siri C, Pezzoli G, Bech P.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:131-137. doi: 10.1016/j.pnpbp.2017.10.024. Epub 2017 Nov 1.

PMID:
29100973
15.

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

Angelova PR, Barilani M, Lovejoy C, Dossena M, Viganò M, Seresini A, Piga D, Gandhi S, Pezzoli G, Abramov AY, Lazzari L.

Redox Biol. 2018 Apr;14:474-484. doi: 10.1016/j.redox.2017.10.016. Epub 2017 Oct 20.

16.

Parkin absence accelerates microtubule aging in dopaminergic neurons.

Cartelli D, Amadeo A, Calogero AM, Casagrande FVM, De Gregorio C, Gioria M, Kuzumaki N, Costa I, Sassone J, Ciammola A, Hattori N, Okano H, Goldwurm S, Roybon L, Pezzoli G, Cappelletti G.

Neurobiol Aging. 2018 Jan;61:66-74. doi: 10.1016/j.neurobiolaging.2017.09.010. Epub 2017 Sep 20.

PMID:
29040870
17.

Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.

Brumberg J, Küsters S, Al-Momani E, Marotta G, Cosgrove KP, van Dyck CH, Herrmann K, Homola GA, Pezzoli G, Buck AK, Volkmann J, Samnick S, Isaias IU.

Ann Clin Transl Neurol. 2017 Aug 11;4(9):632-639. doi: 10.1002/acn3.438. eCollection 2017 Sep.

18.

DNAJC12 and dopa-responsive nonprogressive parkinsonism.

Straniero L, Guella I, Cilia R, Parkkinen L, Rimoldi V, Young A, Asselta R, Soldà G, Sossi V, Stoessl AJ, Priori A, Nishioka K, Hattori N, Follett J, Rajput A, Blau N, Pezzoli G, Farrer MJ, Goldwurm S, Rajput AH, Duga S.

Ann Neurol. 2017 Oct;82(4):640-646. doi: 10.1002/ana.25048. Epub 2017 Oct 11.

PMID:
28892570
19.

Erratum to: Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Sep;264(9):2051. doi: 10.1007/s00415-017-8585-x. No abstract available.

20.

Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.

Cilia R, Asselta R, Cereda E, Benfante R, Barbella G, Vallauri D, Marabini L, Fornasari D, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):323-324. doi: 10.1136/jnnp-2017-316235. Epub 2017 Jul 19. No abstract available.

PMID:
28724719
21.

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G.

Neurology. 2017 Aug 1;89(5):432-438. doi: 10.1212/WNL.0000000000004175. Epub 2017 Jul 5.

22.

Dietary habits in Parkinson's disease: Adherence to Mediterranean diet.

Cassani E, Barichella M, Ferri V, Pinelli G, Iorio L, Bolliri C, Caronni S, Faierman SA, Mottolese A, Pusani C, Monajemi F, Pasqua M, Lubisco A, Cereda E, Frazzitta G, Petroni ML, Pezzoli G.

Parkinsonism Relat Disord. 2017 Sep;42:40-46. doi: 10.1016/j.parkreldis.2017.06.007. Epub 2017 Jun 15.

PMID:
28647435
23.

Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G.

J Neurol. 2017 Jun;264(6):1254-1263. doi: 10.1007/s00415-017-8523-y. Epub 2017 May 26. Erratum in: J Neurol. 2017 Aug 22;:.

24.

Protein-redistribution diet in a case of tyrosine hydroxylase enzyme deficiency.

Cassani E, Barichella M, Ferri V, Pusani C, Goldwurm S, Siri C, Zini M, Zorzi GS, Cereda E, Iorio L, Pinelli G, Sacilotto G, Pezzoli G.

Mov Disord. 2017 May;32(5):794-795. doi: 10.1002/mds.26963. Epub 2017 Mar 28. No abstract available.

PMID:
28370247
25.

A focus on Rome III criteria for the assessment of constipation in Parkinson's disease.

Barichella M, Cereda E, Cassani E, Frazzitta G, Pezzoli G.

Mov Disord. 2017 Apr;32(4):630. doi: 10.1002/mds.26974. Epub 2017 Mar 25. No abstract available.

PMID:
28343368
26.

Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.

Clerici I, Ferrazzoli D, Maestri R, Bossio F, Zivi I, Canesi M, Pezzoli G, Frazzitta G.

PLoS One. 2017 Feb 3;12(2):e0170927. doi: 10.1371/journal.pone.0170927. eCollection 2017.

27.

Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.

Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, Ghilardi MF, Matthies C, Steigerwald F, Volkmann J, Isaias IU.

Front Hum Neurosci. 2016 Dec 6;10:611. doi: 10.3389/fnhum.2016.00611. eCollection 2016.

28.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, Cirillo M, Tedeschi G, Zanigni S, Calandra-Buonaura G, Tonon C, Pezzoli G, Cilia R, Zappia M, Nicoletti A, Cicero CE, Tinazzi M, Tocco P, Cardobi N, Quattrone A.

Eur Radiol. 2017 Jun;27(6):2665-2675. doi: 10.1007/s00330-016-4622-x. Epub 2016 Oct 19.

PMID:
27761709
29.

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Soldà G, Seresini A, Seia M, Pezzoli G, Goldwurm S.

Ann Neurol. 2016 Nov;80(5):662-673. doi: 10.1002/ana.24777. Epub 2016 Oct 3.

PMID:
27632223
30.

α-Synuclein is a Novel Microtubule Dynamase.

Cartelli D, Aliverti A, Barbiroli A, Santambrogio C, Ragg EM, Casagrande FV, Cantele F, Beltramone S, Marangon J, De Gregorio C, Pandini V, Emanuele M, Chieregatti E, Pieraccini S, Holmqvist S, Bubacco L, Roybon L, Pezzoli G, Grandori R, Arnal I, Cappelletti G.

Sci Rep. 2016 Sep 15;6:33289. doi: 10.1038/srep33289.

31.

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.

Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A.

Front Aging Neurosci. 2016 Aug 22;8:196. doi: 10.3389/fnagi.2016.00196. eCollection 2016.

32.

Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease?

Ferrazzoli D, Ortelli P, Maestri R, Bera R, Giladi N, Ghilardi MF, Pezzoli G, Frazzitta G.

Front Aging Neurosci. 2016 Aug 11;8:192. doi: 10.3389/fnagi.2016.00192. eCollection 2016.

33.

Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.

Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, Pinelli G, Privitera G, Cesari I, Faierman SA, Caccialanza R, Pezzoli G, Cereda E.

Neurology. 2016 Sep 20;87(12):1274-80. doi: 10.1212/WNL.0000000000003127. Epub 2016 Aug 19.

PMID:
27543643
34.

Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.

Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L, Ferri V, Privitera G, Pasqua M, Valentino A, Monajemi F, Caronni S, Lignola C, Pusani C, Bolliri C, Faierman SA, Lubisco A, Frazzitta G, Petroni ML, Pezzoli G.

Clin Nutr. 2017 Aug;36(4):1054-1061. doi: 10.1016/j.clnu.2016.06.020. Epub 2016 Jul 5.

PMID:
27406858
35.

Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.

Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.

J Neural Transm (Vienna). 2016 Dec;123(12):1435-1442. Epub 2016 Jun 22.

PMID:
27334897
36.

Mechanical Energy Recovery during Walking in Patients with Parkinson Disease.

Dipaola M, Pavan EE, Cattaneo A, Frazzitta G, Pezzoli G, Cavallari P, Frigo CA, Isaias IU.

PLoS One. 2016 Jun 3;11(6):e0156420. doi: 10.1371/journal.pone.0156420. eCollection 2016.

37.

Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.

Cilia R, Benfante R, Asselta R, Marabini L, Cereda E, Siri C, Pezzoli G, Goldwurm S, Fornasari D.

Parkinsonism Relat Disord. 2016 Aug;29:96-103. doi: 10.1016/j.parkreldis.2016.05.017. Epub 2016 May 17.

PMID:
27237108
38.

Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.

Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G.

J Neurol Sci. 2016 Jun 15;365:175-80. doi: 10.1016/j.jns.2016.04.001. Epub 2016 Apr 16.

39.

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.

Canesi M, Giordano R, Lazzari L, Isalberti M, Isaias IU, Benti R, Rampini P, Marotta G, Colombo A, Cereda E, Dipaola M, Montemurro T, Viganò M, Budelli S, Montelatici E, Lavazza C, Cortelezzi A, Pezzoli G.

J Transl Med. 2016 May 10;14(1):127. doi: 10.1186/s12967-016-0880-2.

40.

Sarcopenia and Dynapenia in Patients With Parkinsonism.

Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E.

J Am Med Dir Assoc. 2016 Jul 1;17(7):640-6. doi: 10.1016/j.jamda.2016.03.016. Epub 2016 Apr 30.

PMID:
27143236
41.

Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.

Biesemeier A, Eibl O, Eswara S, Audinot JN, Wirtz T, Pezzoli G, Zucca FA, Zecca L, Schraermeyer U.

J Neurochem. 2016 Jul;138(2):339-53. doi: 10.1111/jnc.13648. Epub 2016 Jun 2.

42.

Dementia in Parkinson's disease: Is male gender a risk factor?

Cereda E, Cilia R, Klersy C, Siri C, Pozzi B, Reali E, Colombo A, Zecchinelli AL, Mariani CB, Tesei S, Canesi M, Sacilotto G, Meucci N, Zini M, Isaias IU, Barichella M, Cassani E, Goldwurm S, Pezzoli G.

Parkinsonism Relat Disord. 2016 May;26:67-72. doi: 10.1016/j.parkreldis.2016.02.024. Epub 2016 Mar 2.

PMID:
26952697
43.

Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson's disease.

Frazzitta G, Maestri R, Ferrazzoli D, Riboldazzi G, Bera R, Fontanesi C, Rossi RP, Pezzoli G, Ghilardi MF.

J Clin Mov Disord. 2015 Apr 2;2:11. doi: 10.1186/s40734-015-0020-9. eCollection 2015.

44.

Creative Thinking, Professional Artists, and Parkinson's Disease.

Canesi M, Rusconi ML, Moroni F, Ranghetti A, Cereda E, Pezzoli G.

J Parkinsons Dis. 2016;6(1):239-46. doi: 10.3233/JPD-150681.

PMID:
26639447
45.

Balance Dysfunction in Parkinson's Disease: The Role of Posturography in Developing a Rehabilitation Program.

Ferrazzoli D, Fasano A, Maestri R, Bera R, Palamara G, Ghilardi MF, Pezzoli G, Frazzitta G.

Parkinsons Dis. 2015;2015:520128. doi: 10.1155/2015/520128. Epub 2015 Oct 4.

46.

Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.

Fontanesi C, Kvint S, Frazzitta G, Bera R, Ferrazzoli D, Di Rocco A, Rebholz H, Friedman E, Pezzoli G, Quartarone A, Wang HY, Ghilardi MF.

Neurorehabil Neural Repair. 2016 Jun;30(5):411-8. doi: 10.1177/1545968315600272. Epub 2015 Aug 7.

47.

Endothelial progenitor cells: Cardiovascular protection in Parkinson's disease?

Pezzoli G, Cavanna F, Cassani E, Barichella M, Pinelli G, Iorio L, Pusani C, Canesi M, Natuzzi F, Cazzola R, Cestaro B, Cereda E.

Int J Cardiol. 2015 Oct 15;197:200-2. doi: 10.1016/j.ijcard.2015.06.071. Epub 2015 Jun 26. No abstract available.

PMID:
26142206
48.

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients.

Barone P, Santangelo G, Morgante L, Onofrj M, Meco G, Abbruzzese G, Bonuccelli U, Cossu G, Pezzoli G, Stanzione P, Lopiano L, Antonini A, Tinazzi M.

Eur J Neurol. 2015 Aug;22(8):1184-91. doi: 10.1111/ene.12724. Epub 2015 May 12.

49.

Linking microtubules to Parkinson's disease: the case of parkin.

Cappelletti G, Casagrande F, Calogero A, De Gregorio C, Pezzoli G, Cartelli D.

Biochem Soc Trans. 2015 Apr;43(2):292-6. doi: 10.1042/BST20150007. Review.

PMID:
25849932
50.

Differences in muscle strength in parkinsonian patients affected on the right and left side.

Frazzitta G, Ferrazzoli D, Maestri R, Rovescala R, Guaglio G, Bera R, Volpe D, Pezzoli G.

PLoS One. 2015 Mar 25;10(3):e0121251. doi: 10.1371/journal.pone.0121251. eCollection 2015.

Supplemental Content

Loading ...
Support Center